![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gynecological Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1531987
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
AbstractBackground: Elevated inflammatory markers are commonly linked to poor prognoses in cancer patients, while optimal nutritional status correlates with improved survival outcomes. This study aimed to explore the interplay between nutritional and inflammatory markers and their impact on postoperative outcomes in ovarian cancer patients through a retrospective analysis. Methods: Data were retrospectively retrieved from patients diagnosed with ovarian cancer who required surgical intervention at the Department of Obstetrics and Gynecology. Overall survival (OS) and cancer-specific survival (CSS) were monitored during follow-up. Kaplan-Meier survival curves were employed to assess OS and CSS across different patient cohorts, evaluating the prognostic significance of nutritional and inflammatory markers. Nomograms for predicting OS and CSS at one, three, and five years postoperatively were constructed, followed by external validation.Results: The prognostic nutritional index (PNI) and Naples prognostic score (NPS) exhibited a significant correlation with OS and CSS in postoperative ovarian cancer patients (p < 0.05). Analysis indicated that patients with a PNI > 51.2 demonstrated the most favorable survival outcomes. Furthermore, those with a low-NPS (L-NPS) had notably better survival rates compared to their high-NPS (H-NPS) counterparts. Independent OS predictors included age, PNI, NPS, histological type, tumor size, targeted therapy, and diabetes. Similarly, the CSS prediction model incorporated age, NPS, tumor size, targeted therapy, and diabetes. The nomograms demonstrated robust predictive accuracy for three- and five-year survival, though one-year calibration curves showed limited agreement. Despite slightly reduced external validation performance compared to the initial sample, the model maintained strong predictive capability.Conclusions: The nutritional inflammatory index serves as a key independent prognostic marker for OS and CSS in ovarian cancer patients. Nomograms based on PNI and NPS provide valuable prognostic insights for postoperative management. Incorporating these indices into clinical practice could improve patient stratification and guide personalized treatment plans.
Keywords: nutritional inflammatory markers, PNI, NPS, ovarian cancer, prognosis
Received: 21 Nov 2024; Accepted: 10 Feb 2025.
Copyright: © 2025 Zhang, Xing, Liang, Yang, Ma, Chen and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Weipei Zhu, Second Affiliated Hospital of Soochow University, Suzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.